It is also noteworthy that the majority of LRRK2 biomarkers are based on readouts from peripheral immune cells, and the extent to which LRRK2 in these cells may contribute to PD pathogenesis remains to be determined, as most peripheral LRRK2 readouts do not seem to associate with clinical disease rating scales. Here, LRRK2 is linked to Parkinson disease.